PER-009-04已完成未知
STUDY OF EVALUATION OF PERIOPERATIVE ISCHEMIA (POISE)
POPULATION HEALTH RESEARCH INSTITUTE DE LA UNIVERSIDAD MC MASTER DE CANADA,0 个研究点目标入组 0 人开始时间: 2004年4月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •1. They are> 45 years old
- •2. They have an expectation of postoperative stay> at 24 hours for surgical reasons
- •3. Meet any of the following 6 criteria:
- •A. history of coronary artery disease
- •B. Vascular artery disease
- •C. History of Stroke
- •D. Hospitalization by ICC within 3 years prior to randomization.
- •E. Patients going to vascular surgery
排除标准
- •1. Contraindication for metoprolol
- •2. There is a clinical need for beta-blocker use preoperatively or during the first 30 days postoperatively
- •3. Previous adverse reaction to a beta blocker
- •4. Coronary revascularization surgery in the previous 5 years and no evidence of cardiac ischemia since surgery
- •5. Patients who undergo low-risk surgical procedures
研究者
相似试验
已完成
不适用
Perioperative ischemic evaluation study (POISE study)CardiovascularCirculatory SystemISRCTN17233551McMaster University (Canada)10,000
招募中
3 期
â??Evaluation of tranexamic acid compared with placebo among patients with or at risk of heart disease undergoing surgeries not related to the heart, on bleeding and blood vessel occlusive outcomesCTRI/2019/06/019833Population Health Research Institute
进行中（未招募）
1 期
Evaluation of strategies aiming at controlling perioperative ischemia - 3 (POISE-3)The occurrence of life-threatening, major, and critical organ bleeding in patients who are undergoing noncardiac surgery.MedDRA version: 23.1Level: LLTClassification code 10051014Term: Post procedural bleedingSystem Organ Class: 100000004863EUCTR2018-000539-29-ITHamilton Health Sciences Corporation10,000
已完成
3 期
Peri-Operative ISchemic Evaluation-3 Trialvascular events1001928010023213heart failureNL-OMON48217Population Health Research Institute400
进行中（未招募）
不适用
eriOperative ISchemic Evaluation-2 TrialEUCTR2009-018173-31-ATPopulation Health Research Institute10,000